ArticleNeuro-oncology2019

Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.

Shuang G Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.